Article

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

2020-07-17

Abstract excerpt

<title>Abstract</title> <p>Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized DNA. In response to the ongoing global pandemic caused by SARS coronavirus-2 (SARS-CoV-2),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ea8db727-56c4-5b0e-9cd3-82adc876a6ca
DOI: 10.21203/rs.3.rs-40198/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformDOI 10.21203/rs.3.rs-40198/v1Read

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformSemantic proximity Read

Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineSemantic proximity Read

Design and Immune Profile of Multi-Epitope Synthetic Antigen Vaccine Against SARS-CoV-2: An In Silico and In Vivo ApproachSemantic proximity Read

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccinationSemantic proximity Read

Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variantsSemantic proximity Read

The Evolution of Poxvirus VaccinesSemantic proximity Read

Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adultsSemantic proximity Read

Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 VariantsSemantic proximity Read

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2Semantic proximity Read

Strong Immunogenicity & Protection in Mice with Placcine: A Covid-19 DNA Vaccine Formulated with a Functional PolymerSemantic proximity Read

Rapid development of a synthetic DNA vaccine for COVID-19Semantic proximity Read

Poxviral promoters for improving the immunogenicity of MVA delivered vaccinesSemantic proximity Read